TRUE3D
LIVE

Serial Number

99890985

Owner

Stellaromics, Inc.

Attorney

Aaron D. Hendelman

Filing Date

Jun 17, 2026

Add to watchlist:

No watchlists yet
View on USPTO

TRUE3D Trademark

Serial Number: 99890985

TRUE3D is a trademark filed by Stellaromics, Inc. on June 17, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Stellaromics, Inc. (8 trademarks)

321 Harrison Avenue
Boston, MA 02118

Entity Type: 03

Trademark Details

Filing Date

June 17, 2026

Registration Date

Not Registered

Goods & Services

Scientific research and analysis, namely, in situ multi-omic research and analysis, spatial transcriptomics research and analysis, and protein research and analysis; Clinical research in the fields of in situ multi-omic analysis, spatial transcriptomics, and protein analysis; Analysis, evaluation, and development of therapeutics medicines for research, scientific, and clinical use

Medical diagnostic testing and reporting services in the fields of in situ multi-omic analysis, spatial transcriptomics, and protein analysis

Medical instruments, namely, instruments for in situ multi-omic analysis, for diagnostic purposes

Scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of biomolecules and spatial interactions between biomolecules and cells in situ; Medical laboratory research instruments for in situ multi-omic analysis, spatial transcriptomics, and protein analysis

Chemical reagents for scientific and research use, namely, multi-omic reagents for research, scientific, and clinical laboratory use; Biomarker reagents for research, scientific, and clinical laboratory use

Clinical medical reagents, namely, multi-omic reagents for medical use; Diagnostic biomarker reagents for clinical medical purposes

Filing History

APPLICATION FILING RECEIPT MAILED
Jun 17, 2026 MAFR
NEW APPLICATION ENTERED
Jun 17, 2026 NWAP